Early detection of albuminuria can enable administration of therapeutic interventions that improve clinical outcomes in patients at elevated risk for chronic kidney disease (CKD). We investigated the impact of smartphone-enabled home urinary albumin-to-creatinine ratio (UACR) testing on albuminuria screening and clinical management of these patients.